CN106950095B - Method for reducing detection interference of lipemia sample - Google Patents
Method for reducing detection interference of lipemia sample Download PDFInfo
- Publication number
- CN106950095B CN106950095B CN201710211978.6A CN201710211978A CN106950095B CN 106950095 B CN106950095 B CN 106950095B CN 201710211978 A CN201710211978 A CN 201710211978A CN 106950095 B CN106950095 B CN 106950095B
- Authority
- CN
- China
- Prior art keywords
- lipase
- sample
- buffer solution
- detection
- lipemia
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/34—Purifying; Cleaning
Abstract
The invention relates to a method for reducing the interference of the detection of a lipemic sample, which comprises the following steps of preparing a lipase buffer solution: taking 1-2.5 g of lipase, 1-2 g of co-lipase and 4-10ml of dipotassium hydrogen phosphate-potassium dihydrogen phosphate buffer solution, placing the three into a glass container, uniformly mixing and dissolving to obtain a prepared solution, wherein the lipase activity in the prepared solution is higher than 500 u/L; adding 5-10% of the prepared lipase buffer solution into a lipemia sample, and incubating for 10-20 min; and (4) centrifuging by using a centrifuge, wherein the rotating speed of the centrifuge is controlled to be 1800-3000 rpm. The method does not need to adopt an ultracentrifuge with high requirement and high price, and has simple detection process and small detection result error.
Description
Technical Field
The invention relates to a method for reducing the detection interference of a lipemia sample.
Background
The existing methods for detecting blood samples by using a biochemical analyzer are all spectrophotometry, and the lipemia sample in the blood sample has obvious scattering effect on light with various wavelengths, so that the results of the biochemical analyzer are generally greatly influenced, and the detection results of the biochemical analyzer are inaccurate. Currently, for the detection of a lipemia sample, an ultracentrifugation method or a dilution method is usually used for processing the lipemia sample before the detection so as to reduce the influence of the lipemia on the detection result. However, both of these detection methods have drawbacks: the ultracentrifugation method is characterized in that the lipid and serum of a lipid blood sample are layered by an ultracentrifuge and then are respectively detected, and the ultracentrifuge is expensive and can not be prepared in a common laboratory, and other substances in the blood are layered after ultracentrifugation, namely, not only two layers of the lipid and the serum are formed, so that the detection trouble is caused; the dilution method is to dilute the lipemia sample to a thinner concentration in order to ensure the light transmittance of the spectrophotometry, and the detection result of the lipemia sample with the thinner concentration has a great error directly. Therefore, the invention provides a method for reducing the detection interference of the lipemia sample, which becomes a research problem of the lipemia sample detection in a laboratory.
Disclosure of Invention
The invention aims to provide a method for reducing the detection interference of a lipemia sample, which does not need to adopt an ultracentrifuge with high requirement and high price, and has simple detection process and small detection result error.
In order to achieve the above purpose, the invention adopts the technical scheme that: a method of reducing interference in the detection of a lipemic sample comprising the steps of:
(1) preparing a lipase buffer: taking 1-2.5 g of lipase, 1-2 g of co-lipase and 4-10ml of dipotassium hydrogen phosphate-potassium dihydrogen phosphate buffer solution, placing the three into a glass container, uniformly mixing and dissolving to obtain a prepared solution, wherein the lipase activity in the prepared solution is higher than 500 u/L;
(2) adding 5-10% of the lipase buffer solution prepared in the step (1) into a lipemia sample, and incubating for 10-20 min;
(3) and (4) centrifuging by using a centrifuge, wherein the rotating speed of the centrifuge is controlled to be 1800-3000 rpm.
Further, the pH of the dipotassium hydrogen phosphate-potassium dihydrogen phosphate buffer solution is 7.5.
The invention has the technical effects that: because the thick chylemia is caused by chylemon in blood, and the main component of the chylemon is triglyceride, the triglyceride is decomposed by adding lipase, the glycerol and the fatty acid which are decomposed by the triglyceride are micromolecule substances, and the glycerol and the fatty acid are components of blood fat, and then the triglyceride and the fatty acid are centrifugally treated by a common centrifugal machine (the rotating speed reaches 1800 revolutions per minute), only a blood fat layer and a blood serum layer are separated after centrifugation, so that the scattering of the chylemon to light is eliminated, the detection interference of a lipemia sample is reduced, an ultracentrifugal machine with high requirement and high price is not needed, the detection process is simple, and the detection result error is small. The auxiliary lipase has the function of increasing the activity of lipase, and the dipotassium hydrogen phosphate-potassium dihydrogen phosphate buffer solution has the function of ensuring the activity of the lipase, so that the effective use of the lipase buffer solution is ensured.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the embodiments of the present invention, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
A method of reducing interference in the detection of a lipemic sample comprising the steps of:
(1) preparing a lipase buffer: taking 1-2.5 g of lipase, 1-2 g of co-lipase and 4-10ml of dipotassium hydrogen phosphate-potassium dihydrogen phosphate buffer solution, placing the three into a glass container, uniformly mixing and dissolving to obtain a prepared solution, wherein the lipase activity in the prepared solution is higher than 500 u/L;
(2) adding 5-10% of the lipase buffer solution prepared in the step (1) into a lipemia sample, and incubating for 10-20 min;
(3) and (4) centrifuging by using a centrifuge, wherein the rotating speed of the centrifuge is controlled to be 1800-3000 rpm.
Further, the pH of the dipotassium hydrogen phosphate-potassium dihydrogen phosphate buffer solution is 7.5.
Because the thick chylemia is caused by chylemon in blood, and the main component of the chylemon is triglyceride, the triglyceride is decomposed by adding lipase, the glycerol and the fatty acid which are decomposed by the triglyceride are micromolecule substances, and the glycerol and the fatty acid are components of blood fat, and then the triglyceride and the fatty acid are centrifugally treated by a common centrifugal machine (the rotating speed reaches 1800 revolutions per minute), only a blood fat layer and a blood serum layer are separated after centrifugation, so that the scattering of the chylemon to light is eliminated, the detection interference of a lipemia sample is reduced, an ultracentrifugal machine with high requirement and high price is not needed, the detection process is simple, and the detection result error is small. In addition, after the step (2), a slight flocculent precipitate, which is a lipoprotein component remaining after the decomposition of the blood lipid particles and is also a blood lipid component, may appear in the severe blood lipid sample, and thus the detection result is not affected, and then the step (3) is similarly started. The auxiliary lipase has the function of increasing the activity of lipase, and the dipotassium hydrogen phosphate-potassium dihydrogen phosphate buffer solution has the function of ensuring the activity of the lipase, so that the effective use of the lipase buffer solution is ensured.
It will be evident to those skilled in the art that the invention is not limited to the details of the foregoing illustrative embodiments, and that the present invention may be embodied in other specific forms without departing from the spirit or essential attributes thereof.
Claims (2)
1. A method for reducing interference in the detection of a lipemic sample, comprising the steps of:
(1) preparing a lipase buffer: 1-2.5 g of lipase, 1-2 g of co-lipase and 4-10ml of dipotassium hydrogen phosphate-potassium dihydrogen phosphate buffer solution are taken, the three are placed in a glass container and uniformly mixed and dissolved, and the lipase activity in the obtained prepared solution is higher than 500 u/L;
(2) adding 5-10% of the lipase buffer solution prepared in the step (1) into a lipemia sample, and incubating for 10-20 min;
(3) and (4) centrifuging by using a centrifuge, wherein the rotating speed of the centrifuge is controlled to be 1800-3000 rpm.
2. The method of claim 1, wherein the step of reducing interference in the detection of the lipemic sample comprises: the pH value of the dipotassium hydrogen phosphate-potassium dihydrogen phosphate buffer solution is 7.5.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710211978.6A CN106950095B (en) | 2017-04-01 | 2017-04-01 | Method for reducing detection interference of lipemia sample |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710211978.6A CN106950095B (en) | 2017-04-01 | 2017-04-01 | Method for reducing detection interference of lipemia sample |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN106950095A CN106950095A (en) | 2017-07-14 |
| CN106950095B true CN106950095B (en) | 2020-01-10 |
Family
ID=59474866
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710211978.6A Active CN106950095B (en) | 2017-04-01 | 2017-04-01 | Method for reducing detection interference of lipemia sample |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106950095B (en) |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1888862A (en) * | 2005-06-29 | 2007-01-03 | 中生北控生物科技股份有限公司 | Low-density lipoprotein cholesterol quantitative determining method reagent and reagent kit |
| CN1914333A (en) * | 2004-01-29 | 2007-02-14 | 协和梅迪克斯株式会社 | Method, reagent, and kit for determining cholesterol in very-low-density lipoprotein remnant (vldl remnant) |
| CN101065495A (en) * | 2004-11-29 | 2007-10-31 | 株式会社Jimro | Method of measuring cholesterol in remnant-like lipoproteins |
| CN102539731A (en) * | 2012-01-09 | 2012-07-04 | 宁波天康生物科技有限公司 | Reagent and kit for quantitatively determining low-density lipoprotein cholesterol (LDL-C) in serum |
| CN104583419A (en) * | 2012-04-20 | 2015-04-29 | 电化生研株式会社 | Method for removal of triglycerides in lipoproteins other than low-density lipoproteins |
| CN104995310A (en) * | 2012-12-10 | 2015-10-21 | 赛拉诺斯股份有限公司 | Rapid, low-sample-volume cholesterol and triglyceride assays |
-
2017
- 2017-04-01 CN CN201710211978.6A patent/CN106950095B/en active Active
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1914333A (en) * | 2004-01-29 | 2007-02-14 | 协和梅迪克斯株式会社 | Method, reagent, and kit for determining cholesterol in very-low-density lipoprotein remnant (vldl remnant) |
| CN101065495A (en) * | 2004-11-29 | 2007-10-31 | 株式会社Jimro | Method of measuring cholesterol in remnant-like lipoproteins |
| CN1888862A (en) * | 2005-06-29 | 2007-01-03 | 中生北控生物科技股份有限公司 | Low-density lipoprotein cholesterol quantitative determining method reagent and reagent kit |
| CN102539731A (en) * | 2012-01-09 | 2012-07-04 | 宁波天康生物科技有限公司 | Reagent and kit for quantitatively determining low-density lipoprotein cholesterol (LDL-C) in serum |
| CN104583419A (en) * | 2012-04-20 | 2015-04-29 | 电化生研株式会社 | Method for removal of triglycerides in lipoproteins other than low-density lipoproteins |
| CN104995310A (en) * | 2012-12-10 | 2015-10-21 | 赛拉诺斯股份有限公司 | Rapid, low-sample-volume cholesterol and triglyceride assays |
Also Published As
| Publication number | Publication date |
|---|---|
| CN106950095A (en) | 2017-07-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3193634B2 (en) | LDL cholesterol determination method | |
| DK2116612T3 (en) | REAGENT FOR DETERMINING QUANTITY OF LOW DENSITY LOW DENSITY LIPOPROTEIN | |
| Hurst et al. | Optimized assay for serum angiotensin-converting enzyme activity. | |
| CN106383116B (en) | A kind of kit detecting high-density lipoprotein cholesterol | |
| CA1311432C (en) | Composition for reducing turbidity in samples of biological fluids | |
| EP1930442B1 (en) | Method and kit for quantitative determination of small, dense ldl cholesterol | |
| CN1745303B (en) | Method of quantifying small-sized low density lipoprotein | |
| CN107561297B (en) | Reagent for blood fat typing detection | |
| Wang et al. | Liraglutide reduces oxidized LDL-induced oxidative stress and fatty degeneration in Raw 264.7 cells involving the AMPK/SREBP1 pathway | |
| NO162094B (en) | PROCEDURE FOR DETERMINING LOW DENSITY LIPOPRLDL) AND REAGENT FOR IMPLEMENTING IT. | |
| CN103589776A (en) | Small and dense low-density lipoprotein cholesterol determination kit | |
| CN106950095B (en) | Method for reducing detection interference of lipemia sample | |
| JP5464475B2 (en) | Pesticide residue measurement method | |
| Gardiner et al. | A practical method for reducing the interference due to lipaemia in coagulation tests | |
| JP7022538B2 (en) | Preparation of seborrheic plasma or serum samples for determination of lipid disturbance | |
| CN111537315B (en) | Erythrocyte membrane separation liquid and erythrocyte membrane separation method | |
| CN114755085A (en) | Preparation and application of glycosylated hemoglobin quality control product | |
| Mainard et al. | Variations in lipoproteins, hormones and blood glucose during the early acute phase of myocardial infarction | |
| CN112304903A (en) | Method for detecting concentration of chloride ions in turbid formed liquid | |
| CN108226127A (en) | Measure the method for plasmodium content and the system of detection plasmodium content | |
| CN110082346B (en) | Apolipoprotein E detection kit | |
| CN108489920A (en) | The detection method of worm's ovum content and application in broken head | |
| EP0144367B1 (en) | Method and reagent for the direct detection of an analyte after the specific elimination of colloidal particles in aqueous solutions of biological origin | |
| Rahman | Easy method of detection of chyle in urine | |
| CN110679983B (en) | Reconstituted tobacco coating liquid purity detection method based on composite washing technology |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| CP01 | Change in the name or title of a patent holder | ||
| CP01 | Change in the name or title of a patent holder |
Address after: 230000, building 9, Xing Lu tech Industrial Park, Luyang Industrial Zone, Hefei, Anhui Patentee after: Hefei Dean Medical Laboratory Co., Ltd. Address before: 230000, building 9, Xing Lu tech Industrial Park, Luyang Industrial Zone, Hefei, Anhui Patentee before: HEFEI DIAN MEDICAL LABORATORY Co.,Ltd. |
|
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20201217 Address after: 242000 buildings 9 and 10, 15 Huancheng North Road, Xuancheng City, Anhui Province Patentee after: Xuancheng Dean medical laboratory Co.,Ltd. Address before: 230000 Building 9, Xinglu science and Technology Industrial Park, Luyang Industrial Park, Hefei City, Anhui Province Patentee before: Hefei Dean Medical Laboratory Co.,Ltd. |
|
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20211018 Address after: 230000 Building 9, Xinglu science and Technology Industrial Park, Luyang Industrial Park, Hefei City, Anhui Province Patentee after: Hefei Dean Medical Laboratory Co.,Ltd. Address before: 242000 buildings 9 and 10, 15 Huancheng North Road, Xuancheng City, Anhui Province Patentee before: Xuancheng Dean medical laboratory Co.,Ltd. |